Comparison of the Clinical Manifestations of Type 2 Diabetes Mellitus Between Rhesus Monkey (Macaca mulatta lasiotis) and Human Being

Objectives Type 2 diabetes mellitus (T2DM) is the most common form of diabetes. To determine the similarities of development of T2DM between rhesus monkey [Macaca mulatta lasiotis (M. m. lasiotis)] and human being, the clinical parameters were determined during a period of 2 years in 60 adult male rhesus monkeys (M. m. lasiotis). Methods Sixty male monkeys whose fasting plasma glucose (FPG) level less than or equal to 5 mmol/L (90 mg/dL) were enrolled in this study. Of these, 50 monkeys aged 7 to 20 years were fed with high-fat diet and 10 aged 4 to 10 years fed with standard diet as normal monkeys. Body weight, body mass index, FPG, fasting plasma insulin, and hemoglobin A1c levels were measured and calculated. The responses of insulin and glucose levels to intravenous glucose tolerance test were analyzed. Results Of 50 monkeys fed with high-fat diet, 8 developed overt T2DM, 26 experienced impaired glucose tolerance and impaired fasting glucose, and FPG of 16 monkeys was normal. All monkeys with impaired glucose tolerance experienced obesity, compensatory increase of fasting plasma insulin, significant decline of postprandial glucose clearance rate (KGluc5-20), and decreased insulin secretion. Conclusions In conclusion, rhesus monkey (M. m. lasiotis) has many similarities with human beings in terms of clinical manifestations and risk factors at different diabetes stages.

[1]  G. Gallus,et al.  Age- and sex-specific prevalences of diabetes and impaired glucose regulation in 13 European cohorts. , 2003, Diabetes care.

[2]  T. V. van Haeften.  Early disturbances in insulin secretion in the development of type 2 diabetes mellitus. , 2002, Molecular and cellular endocrinology.

[3]  J. Shaw,et al.  Global estimates of the prevalence of diabetes for 2010 and 2030. , 2010, Diabetes research and clinical practice.

[4]  Lothar Siekmann,et al.  State of the art in trueness and interlaboratory harmonization for 10 analytes in general clinical chemistry. , 2008, Archives of pathology & laboratory medicine.

[5]  H. Kamiya,et al.  Insulin, C-peptide, hyperglycemia, and central nervous system complications in diabetes. , 2004, European journal of pharmacology.

[6]  David E Bruns,et al.  Stabilization of glucose in blood samples: why it matters. , 2009, Clinical chemistry.

[7]  A. Scheen.  Diabetes mellitus in the elderly: insulin resistance and/or impaired insulin secretion? , 2005, Diabetes & metabolism.

[8]  P. Wahl,et al.  Association of fasting glucose levels with a delayed secretion of insulin after oral glucose in subjects with glucose intolerance. , 1990, The Journal of clinical endocrinology and metabolism.

[9]  C. Boesch,et al.  Interaction between dietary lipids and physical inactivity on insulin sensitivity and on intramyocellular lipids in healthy men. , 2005, Diabetes care.

[10]  D. Pereg,et al.  Normal fasting plasma glucose levels and type 2 diabetes in young men. , 2005, The New England journal of medicine.

[11]  J. Shaw,et al.  High incidence of type 2 diabetes and increasing conversion rates from impaired fasting glucose and impaired glucose tolerance to diabetes in Mauritius , 2004, Journal of internal medicine.

[12]  G. Roglić,et al.  Mortality attributable to diabetes: estimates for the year 2010. , 2010, Diabetes research and clinical practice.

[13]  B. Hansen,et al.  Heterogeneity of insulin responses: phases leading to Type 2 (non-insulin-dependent) diabetes mellitus in the rhesus monkey , 1986, Diabetologia.

[14]  M. D. Di Carli,et al.  Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes. , 2003, Journal of the American College of Cardiology.

[15]  K. Alberti,et al.  What is Blood Glucose: Can it be Measured? , 1990, Diabetic medicine : a journal of the British Diabetic Association.

[16]  R. Hanson,et al.  The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. , 2000, Diabetes care.

[17]  P. Sullivan,et al.  The impact of obesity on diabetes, hyperlipidemia and hypertension in the United States , 2008, Quality of Life Research.

[18]  E. Ford,et al.  Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies. , 2004, Archives of internal medicine.

[19]  B. Hansen,et al.  Age-related changes in metabolic parameters of nonhuman primates. , 2004, The journals of gerontology. Series A, Biological sciences and medical sciences.

[20]  Leif Groop,et al.  Genetic dissection of type 2 diabetes , 2009, Molecular and Cellular Endocrinology.

[21]  Zhengli Chen,et al.  In vivo assessment of mitochondrial toxicity of metacavir in Rhesus monkeys after three months of intravenous administration , 2009, Acta Pharmacologica Sinica.

[22]  H. Keen,et al.  Mortality and causes of death in the WHO multinational study of vascular disease in diabetes , 2001, Diabetologia.

[23]  T. Méas,et al.  Abnormalities in insulin secretion in type 2 diabetes mellitus. , 2008, Diabetes & metabolism.

[24]  D. Porte,et al.  Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests. , 1976, The Journal of clinical endocrinology and metabolism.

[25]  B. Hansen,et al.  Nuclear magnetic resonance-determined lipoprotein abnormalities in nonhuman primates with the metabolic syndrome and type 2 diabetes mellitus. , 2007, Metabolism: clinical and experimental.

[26]  Kylie Kavanagh,et al.  Old world nonhuman primate models of type 2 diabetes mellitus. , 2006, ILAR journal.

[27]  A de A Pupo,et al.  [Diagnosis and classification of diabetes]. , 1986, AMB : revista da Associacao Medica Brasileira.

[28]  T. W. Haeften.  Early disturbances in insulin secretion in the development of type 2 diabetes mellitus , 2002, Molecular and Cellular Endocrinology.